Search
for
Sort by
Research 121–150 of 1000+
- The Critical Roles of Serum/Glucocorticoid-Regulated Kinase 3 (SGK3) in the Hair Follicle Morphogenesis and Homeostasis
- Purified Vitexin Compound 1 Inhibits UVA-Induced Cellular Senescence in Human Dermal Fibroblasts by Binding Mitogen-Activated Protein Kinase 1
- Treatment of alopecia universalis with topical Janus kinase inhibitors – a double blind, placebo, and active controlled pilot study
- Translational Positioning of Janus Kinase (JAK) Inhibitors in Alopecia Areata
- New small molecules in dermatology: for the autoimmunity, inflammation and beyond
- A phase 2a randomized, placebo-controlled study to evaluate the efficacy and safety of the oral Janus kinase inhibitors ritlecitinib and brepocitinib in alopecia areata: 24-week results
- Targeting the Janus Kinase Family in Autoimmune Skin Diseases
- Ritlecitinib: First Approval
- Efficacy and safety of deuruxolitinib, an oral selective Janus kinase inhibitor, in adults with alopecia areata: Results from the Phase 3 randomized, controlled trial (THRIVE-AA1)
- Janus kinase inhibitors for alopecia areata: A narrative review
- Novel Janus Kinase Inhibitors in the Treatment of Dermatologic Conditions
- Inibidores das Janus Associated Kinases na Terapêutica Farmacológica
- Vandetanib-associated alopecia areata in a patient with metastatic medullary thyroid cancer
- Use of oral Janus kinase inhibitors for the treatment of severe alopecia areata: narrative review and real-world experience
- Clinical evidence for JAK inhibition in alopecia areata: A comprehensive review
- Identifying the Target Cells and Mechanisms of Merkel Cell Polyomavirus Infection
- MIM and Cortactin Antagonism Regulates Ciliogenesis and Hedgehog Signaling
- Self-organization process in newborn skin organoid formation inspires strategy to restore hair regeneration of adult cells
- Protein Kinase C as a Therapeutic Target
- The Changing Landscape of Alopecia Areata: The Therapeutic Paradigm
- Protein Kinase Cε, which Sensitizes Skin to Sun's UV Radiation–Induced Cutaneous Damage and Development of Squamous Cell Carcinomas, Associates with Stat3
- Role of janus kinase inhibitors in the treatment of alopecia areata
- TCL1 transgenic mouse model as a tool for the study of therapeutic targets and microenvironment in human B-cell chronic lymphocytic leukemia
- Suppression of Wnt/β-catenin signaling by EGF receptor is required for hair follicle development
- Tofacitinib (Selective Janus Kinase Inhibitor 1 and 3): A promising therapy for the treatment of alopecia areata: A case report of six patients
- The Use of Janus Kinase Inhibitors in Alopecia Areata: A Review of the Literature
- Janus kinase inhibitors for alopecia areata
- Efficacy and safety of deuruxolitinib, an oral selective Janus kinase 1/2 inhibitor, in adults with alopecia areata: Results from the THRIVE-AA2 Phase 3, randomized, double-blind, controlled trial
- Pyruvate Kinase M2 Role in Cardiovascular Repair
- The relative efficacy of monotherapy with Janus kinase inhibitors, dupilumab and apremilast in adults with alopecia areata: Network meta‐analyses of clinical trials